Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > CG Oncology NMIBC data

<< Previous

Bullboard Posts

Next >>

Comment by Rumpl3StiltSkinon Dec 02, 2022 10:40am

198 Views

Post# 35146269

RE:RE:RE:RE:RE:RE:CG Oncology NMIBC data

Gman620 wrote:
Right. But the behavior of the FDA is also suspect. I feel there is a 'wink' that if you piggyback on (combo with) Keytruda, you get a 'fast pass' to the head of the line for BTD, etc. Anything to sell more Keytruda is good and is an easy road.

Who akes Keytruda again?? Their best bet is to buy out TLT. I think Keytruda is only effective in a certain subset of people who have specific genetics.. TLT should be effective in everyone. If they dont buy out TLT one of their competitors will. The numbers by AA timeline should be very convincing.

<< Previous

Bullboard Posts

Next >>

Gold vs. bitcoin, where should you invest?